SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-019910
Filing Date
2021-08-16
Accepted
2021-08-16 07:50:37
Documents
13
Period of Report
2021-08-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 37839
2 ex99-1.htm EX-99.1 51444
  Complete submission text file 0001493152-21-019910.txt   270262

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE sonn-20210816.xsd EX-101.SCH 3027
4 XBRL LABEL FILE sonn-20210816_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE sonn-20210816_pre.xml EX-101.PRE 22360
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3616
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

IRS No.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35570 | Film No.: 211174574
SIC: 2834 Pharmaceutical Preparations